Axa S.A. Has $6.64 Million Stake in Crocs, Inc. (NASDAQ:CROX)

Axa S.A. grew its holdings in shares of Crocs, Inc. (NASDAQ:CROX) by 5.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,494 shares of the textile maker’s stock after acquiring an additional 2,536 shares during the period. Axa S.A. owned 0.07% of Crocs worth $6,639,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Rise Advisors LLC bought a new stake in shares of Crocs during the 1st quarter valued at about $25,000. GHP Investment Advisors Inc. grew its position in shares of Crocs by 375.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 228 shares of the textile maker’s stock worth $33,000 after buying an additional 180 shares during the period. Blue Trust Inc. increased its stake in shares of Crocs by 19.3% in the 2nd quarter. Blue Trust Inc. now owns 1,001 shares of the textile maker’s stock valued at $144,000 after acquiring an additional 162 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Crocs by 8.9% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,041 shares of the textile maker’s stock valued at $152,000 after acquiring an additional 85 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Crocs by 50.0% during the 2nd quarter. GAMMA Investing LLC now owns 1,068 shares of the textile maker’s stock valued at $156,000 after acquiring an additional 356 shares during the period. 93.44% of the stock is currently owned by institutional investors and hedge funds.

Crocs Trading Down 2.1 %

NASDAQ CROX opened at $144.31 on Friday. The company has a current ratio of 1.50, a quick ratio of 0.95 and a debt-to-equity ratio of 0.93. The firm has a market capitalization of $8.76 billion, a P/E ratio of 11.17, a PEG ratio of 1.44 and a beta of 2.00. The business has a fifty day simple moving average of $135.41 and a 200 day simple moving average of $138.52. Crocs, Inc. has a 12 month low of $74.00 and a 12 month high of $165.32.

Crocs (NASDAQ:CROX) last released its quarterly earnings results on Thursday, August 1st. The textile maker reported $4.01 earnings per share for the quarter, beating analysts’ consensus estimates of $3.59 by $0.42. Crocs had a net margin of 20.02% and a return on equity of 53.20%. The company had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.10 billion. During the same period last year, the firm earned $3.59 earnings per share. The firm’s revenue was up 3.6% on a year-over-year basis. On average, analysts predict that Crocs, Inc. will post 12.85 EPS for the current fiscal year.

Insider Activity

In related news, Director Douglas J. Treff sold 10,594 shares of Crocs stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the sale, the director now directly owns 81,254 shares in the company, valued at $10,756,404.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director John B. Replogle acquired 1,996 shares of the firm’s stock in a transaction that occurred on Friday, August 2nd. The stock was acquired at an average price of $123.96 per share, for a total transaction of $247,424.16. Following the completion of the acquisition, the director now owns 7,064 shares of the company’s stock, valued at approximately $875,653.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Douglas J. Treff sold 10,594 shares of Crocs stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the completion of the sale, the director now directly owns 81,254 shares in the company, valued at approximately $10,756,404.52. The disclosure for this sale can be found here. 2.72% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Barclays decreased their price target on shares of Crocs from $169.00 to $164.00 and set an “overweight” rating for the company in a research note on Friday, August 2nd. StockNews.com upgraded Crocs from a “hold” rating to a “buy” rating in a report on Friday, August 23rd. Wedbush reissued an “outperform” rating and issued a $170.00 price objective on shares of Crocs in a research note on Monday, July 29th. Piper Sandler reaffirmed an “overweight” rating and set a $170.00 target price on shares of Crocs in a research report on Friday, August 23rd. Finally, Bank of America lifted their price target on shares of Crocs from $160.00 to $187.00 and gave the company a “buy” rating in a research report on Thursday, June 20th. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $160.82.

Crocs Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.